ClinicalTrials.gg
Drug

Vincristine Sulfate Liposome clinical trials

A product of Vincristine; its studies count on that page too.

studies test it
12
open now
0
in phase 3
3
first study started
2001

How each study uses Vincristine Sulfate Liposome is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
10 Jul 1963 · ONCOVIN · NDA 014103 (FDA, Drugs@FDA; as Vincristine)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Marqibo
8
Vincristine Sulfate Liposome
4
Vincristine sulfate liposome injection
2
Marqibo® (vincristine sulfate liposomes injection)
2

Studies by the year they started

12 studies that test it; most in 2007 (3)

Studies that test Vincristine Sulfate Liposome, by start year
YearStudies
20011
20051
20073
20101
20121
20131
20151
20172
20201

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
4
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 4

Acrotech Biopharma Inc. (4) · Spectrum Pharmaceuticals, Inc (3) · Children's Oncology Group (1) · Therapeutic Advances in Childhood Leukemia Consortium (1) · Brown University (1) · Wake Forest University Health Sciences (1) · Nanjing Luye Sike Pharmaceutical Co., Ltd. (1)

Often tested with

Tested in the same studies.

Rituximab (2) · Cyclophosphamide (1) · Dactinomycin (1) · Doxorubicin (1) · Etoposide (1) · Bendamustine (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Vincristine Sulfate Liposome is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 12

Given beside what is tested · 7 — Vincristine Sulfate Liposome is usual care or a partner of the new treatment